Indirect comparison of etanercept, infliximab, and adalumimab for psoriatic arthritis: mixed treatment comparison using placebo as common comparator

被引：0
作者：
Alberto Migliore
Emanuele Bizzi
Serena Broccoli
Bruno Laganà
机构：
[1] S. Pietro FBF Hospital,Rheumatology
[2] CRO,Rheumatology, 2nd medical school
[3] Bioikos Pharma,undefined
[4] La Sapienza University,undefined
来源：
Clinical Rheumatology | 2012年 / 31卷
关键词：
Placebo; Primary Endpoint; Infliximab; Etanercept; Adalimumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：193 / 194
页数：1
相关论文
共 40 条
[21]  
Weisman MH(undefined)undefined undefined undefined undefined-undefined
[22]  
Kalden JR(undefined)undefined undefined undefined undefined-undefined
[23]  
Smolen J(undefined)undefined undefined undefined undefined-undefined
[24]  
Antoni C(undefined)undefined undefined undefined undefined-undefined
[25]  
Krueger GG(undefined)undefined undefined undefined undefined-undefined
[26]  
de Vlam K(undefined)undefined undefined undefined undefined-undefined
[27]  
Birbara C(undefined)undefined undefined undefined undefined-undefined
[28]  
Beutler A(undefined)undefined undefined undefined undefined-undefined
[29]  
Guzzo C(undefined)undefined undefined undefined undefined-undefined
[30]  
Zhou B(undefined)undefined undefined undefined undefined-undefined
1234